Champions Oncology (CSBR) Misses Q3 EPS by 10c
Tweet
Share
E-mailGet Alerts CSBR Hot Sheet
Price: $5.20 +3.38%
Financial Fact:
Total costs and operating expenses: 6.19M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Total costs and operating expenses: 6.19M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Champions Oncology (NASDAQ: CSBR) reported Q3 EPS of ($0.16), $0.10 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $12 million versus the consensus estimate of $13.5 million.
For earnings history and earnings-related data on Champions Oncology (CSBR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- TD Cowen Reiterates Buy Rating on NVIDIA (NVDA), 'unlikely to move significantly on earnings'
- Eltek Ltd (ELTK) Reports Q2 EPS of $0.41
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
